The stomach serves as a barrier to enteric infection because of the antibacterial effect of the hydrochloric acid in gastric juice. In this study, we tested the ability of the enteric pathogen Yersinia enterocolitica to tolerate a pH range of 2.0 to 6.0 and found that under the conditions of a normal human fasting stomach (pH < 3 and a gastric emptying time of 2 h), Y. enterocolitica is highly acid resistant, showing approximately 85% survival. The resistance of Y. enterocolitica to acid in vitro depended on the bacterial growth phase and the concentration of urea in the medium, being maximal during stationary phase in the presence of at least 0.3 mM urea. Urease-negative mutants of Y. enterocolitica were constructed by disrupting the urease gene complex of a virulent strain of serogroup O9. Compared with the wild type, these mutants showed an approximately 1,000-fold decrease in the ability to tolerate acid in vitro (<0.08% survival) and a 10-fold reduction in viability after passage through the stomachs of mice. Complementation of the disrupted urease genes in trans restored the ability of urease-negative mutants to tolerate low pH in vitro and gastric acidity to approximately wild-type levels. These findings indicate that urease is responsible for acid resistance in Y. enterocolitica and suggest that urease contributes to the virulence of Y. enterocolitica by enhancing the likelihood of bacterial survival during passage through the stomach.
The contribution of hydrochloric acid in gastric secretions to the establishment of a barrier to intestinal infection is well documented (9, 14) . The corollary of this observation is that the ability of bacteria to resist killing in the stomach at pH Ͻ 3 contributes to virulence by increasing the likelihood of intestinal colonization. The low infectious dose of Shigella species compared with that of other enteric pathogens has been linked to their ability to tolerate acidic pH typical of the range that occurs in the human stomach (15) . Other enteric pathogens such as Salmonella typhimurium can overcome acid stress by the induction of acid tolerance response genes (12) .
Yersinia enterocolitica is an invasive enteric pathogen which gains access to the body by the oral route in contaminated food or water (5, 6) . The bacteria pass though the stomach before colonizing and penetrating the intestinal mucosa to cause a wide spectrum of clinical disorders, ranging from self-limiting enterocolitis to mesenteric lymphadenitis, visceral abscesses, septicemia, and reactive arthritis (5, 6) . Although Y. enterocolitica grows optimally at a pH around 7.0 to 8.0, it is able to grow over a wide pH range from 5.0 to 9.0 (16) and remains viable after 48 h at pH 4.4 (34) . Furthermore, the ability of certain Y. enterocolitica strains to survive the high acidity of some foods suggests that these bacteria are relatively acid tolerant.
The mechanism of acid tolerance of Y. enterocolitica is unknown, but it may conceivably be due to urease activity. This enzyme catalyzes the hydrolysis of urea to form carbon dioxide and ammonia, leading to a net increase in pH. Urease evidently contributes to the virulence of several other bacterial species in a variety of clinical settings (for a review, see reference 27). Most relevant in the current context is the work of Marshall et al. (25) , which showed that urease produced by the gastric pathogen Helicobacter pylori protects it from the bactericidal effects of gastric acid by catalyzing the production of sufficient ammonia to elevate the pH to levels at which the bacteria remain viable. The aim of this study was to determine if urease may allow Y. enterocolitica to resist the antibacterial effects of low pH levels similar to those found in the stomach.
MATERIALS AND METHODS
Bacterial strains and growth conditions. The bacterial strains and plasmids used in this study are listed in Table 1 . Y. enterocolitica strains were grown in brain heart infusion (BHI) broth (Oxoid, Basingstoke, England) or on BHI agar. The presence of pYVe227, the 71.5-kb virulence plasmid of Y. enterocolitica W22073, was determined by plating the bacteria on Columbia agar base (Oxoid) supplemented with 20 mM sodium oxalate and 20 mM MgCl 2 (MOX agar) (18) or on Congo red agar plates (30) . Yersinia selective agar (CIN agar; Oxoid) was used to select for Y. enterocolitica after conjugal matings. E. coli strains were grown in Luria broth or on Luria agar. Bacteria were screened in Christensen's urea broth for the presence of urease activity (4) . Ampicillin (100 g/ml; CSL Ltd., Melbourne, Australia), kanamycin (100 g/ml; Boehringer, Mannheim, Germany), gentamicin (20 g/ml; CSL Ltd.), and tetracycline (25 g/ml; Sigma Chemical Co., St. Louis, Mo.) were added to the culture media when appropriate.
Enzymes and chemicals. Restriction enzymes, Taq DNA polymerase, T7 DNA polymerase, RNase A, and deoxy-and dideoxynucleotide mixes were obtained from Pharmacia, Uppsala, Sweden. T4 DNA ligase, alkaline phosphatase, and the digoxigenin-labeling and detection kit were obtained from Boehringer.
[␣- 35 S]dATP was purchased from DuPont, Wilmington, Del. DNA methods. Plasmid and genomic DNA extractions, restriction enzyme digests, DNA ligations, and transformations into Escherichia coli were performed by standard techniques (1, 31) . Conjugal matings were performed at 28ЊC for 5 h (13), after which the bacteria were plated on CIN agar containing appropriate antibiotics. To determine if a double-crossover event had occurred during homologous recombination, Southern blotting (31) was performed with the 2.1-kb BamHI kanamycin resistance determinant or the 6.6-kb EcoRI-PvuI urease fragment as digoxigenin-labeled DNA probes.
Construction of urease-negative mutants. Insertional inactivation of the urease gene complex of Y. enterocolitica W22703 was accomplished by two methods. The first of these involved transposon mutagenesis with TnphoA as described elsewhere (36) . Resultant mutants were screened for their ability to produce urease in Christensen's urea broth containing kanamycin. The TnphoA insertions were mapped by Southern blot analysis of genomic DNA digested with various enzymes, using different regions of the urease gene complex of Y. enterocolitica A2635 as DNA probes (7) . To map each insertion precisely, the sequence around the insertion point was amplified by PCR with a urease-specific primer (TDK3, 5Ј-GGCAGCCCTTCAACTGA; or S2R, 5Ј-GTGGAAATGTGAACCCA) and a primer directed to the left end of the transposon (24) , under the following conditions: 94ЊC for 60 s, 60ЊC for 60 s, and 72ЊC for 2 min for 30 cycles, with a final extension at 72ЊC for 5 min. The PCR products were purified by gel electrophoresis and filled in by incubation with 4 U of T7 DNA polymerase and 20 M (each) deoxynucleoside triphosphates at 30ЊC for 15 min. They were then cloned into the SmaI site of pT7T319U (Pharmacia) and transformed into E. coli MC1061. The nucleotide sequences of the purified PCR products were determined with a T7 DNA sequencing kit (Pharmacia).
The second mutagenesis technique involved inserting a kanamycin resistance determinant into the gene encoding UreF (7). This gene was chosen for the site of insertion because it contains a unique BglII site into which the kanamycin resistance cassette could be cloned and because disruption of this gene in p19EPv in E. coli renders the bacteria urease negative. The mutagenesis procedure required cloning the 6.6-kb fragment containing the urease gene complex from p19EPv into pRK404, a plasmid which can easily be conjugated into Y. enterocolitica and is stably maintained in this host (17, 26) . pRK404 was digested with HindIII, and the overhang was filled in to create a blunt end. A second digestion was then performed with PstI. p19EPv was digested with EcoRI, and the overhang was also filled in to create a blunt end. Digestion with PstI enabled this fragment to be cloned into the prepared pRK404. The resulting plasmid, termed pRKure ϩ , conferred urease activity when transformed into E. coli MC1061. A urease-negative derivative of this plasmid was created by inserting a 2.1-kb BamHI kanamycin resistance determinant from pJBK81 into the BglII site of pRKure ϩ , 12 bp into the gene encoding UreF (7). The resulting plasmid, termed pRKure Ϫ Kn, was transformed into E. coli SM10 and then introduced into Y. enterocolitica W22703 by conjugal mating, with selection on CIN agar containing kanamycin. In a second step to recombine the disrupted urease gene complex of pRKure Ϫ Kn into the chromosome, Y. enterocolitica W22703 (pRKure Ϫ Kn) was mated with E. coli SM10 harboring the plasmid pPH1JI, which encodes resistance to gentamicin and belongs to the same incompatibility group (IncP) as pRK404. To confirm that a double-recombination event had occurred, urease-negative colonies which grew on CIN agar supplemented with kanamycin and gentamicin were examined by Southern blot analysis. Genomic DNA was digested with SalI and then hybridized with DNA probes prepared from the 2.1-kb kanamycin resistance determinant and the entire 6.6-kb EcoRIPvuI urease gene fragment. One strain in which double recombination was demonstrated was termed W22u Ϫ (pPH1JI). pPH1JI was then cured from this strain by a further mating with E. coli SM10 carrying pME305, a temperaturesensitive IncP plasmid, which was subsequently cured by cultivating W22u Ϫ (pME305) at 37ЊC. Complementation of mutants. pRKure ϩ was introduced into urease-negative mutants of Y. enterocolitica by conjugal mating of the mutant strain with E. coli SM10(pRKure ϩ ). Exconjugants were selected on CIN plates containing tetracycline and kanamycin and examined for urease activity in Christensen's urea broth. Confirmation that the plasmid was maintained and had not recombined into the chromosome was obtained by growing the cultures in the absence of tetracycline or kanamycin and showing that urease activity and resistance to the antibiotics were always lost concurrently.
Urease assay. Bacteria were grown in 50 ml of BHI broth and harvested by centrifugation at 3,500 ϫ g and 4ЊC. The cells were washed three times with 20 mM sodium phosphate buffer (pH 6.8), resuspended in 3 ml of this buffer, and then ruptured in a precooled French pressure cell at 20,000 lb/in 2 . The lysate was centrifuged at 12,000 ϫ g for 15 min to remove cell debris, and the supernatant was used for all assays. The protein concentration in the supernatant was determined by the method of Bradford with a protein dye concentrate (Bio-Rad, Richmond, Calif.) and bovine serum albumin (Sigma) as the standard. Urease activity was assayed by a coupled-enzyme assay as described elsewhere (10) and was expressed as micromoles of urea per minute per milligram of protein.
Growth curves. The growth rates of Y. enterocolitica W22703 and its ureasenegative and trans-complemented mutants were monitored in BHI broth containing appropriate antibiotics. Overnight cultures grown at 28ЊC were diluted in 10 ml of fresh medium in a 50-ml conical flask until they contained ca. 10 4 CFU/ml. The cultures were incubated at 28 or 37ЊC with shaking in an orbital shaking incubator at 200 rpm. The number of viable bacteria in aliquots removed at 4-h intervals was determined on duplicate BHI agar plates.
Susceptibility to acid in vitro. Stationary-phase cultures of Y. enterocolitica strains were diluted 1:10 5 in phosphate-buffered saline (PBS) at pHs from 2.0 to 6.0, containing 3.4 mM urea. After 2 h at 37ЊC, bacteria were enumerated on BHI agar and the counts were compared with those in the inoculum. Strains showing greater than 10% survival at pH 2.5 were considered acid resistant (15) .
Animal experiments. Y. enterocolitica W22703 (wild type) and 584 (a TnphoA urease-negative mutant) and a trans-complemented urease-positive derivative of 584 were examined for their ability to survive passage through the stomach of mice. Each strain was administered perorally to 12 4-week-old BALB/c mice (which had been starved overnight) either via their drinking water, which contained 10 10 CFU/ml, or by gavage with 10 9 CFU in 0.2 ml of distilled water. After 90 min, the mice were killed by CO 2 inhalation. The ileum was removed aseptically and homogenized in PBS. Serial 10-fold dilutions of the homogenate were then plated on CIN agar to determine the number of viable bacteria.
Statistical analysis. Data were analyzed by the Mann-Whitney test. A critical P value of 0.05 was used for all analyses.
RESULTS
Analysis of TnphoA mutants. Approximately 1,600 TnphoA mutant strains were screened for urease activity in Christensen's urea broth. Of these, five lacked the ability to produce urease. Probing of genomic DNA from these mutants with the 6.6-kb urease fragment of p19EPv showed that TnphoA was located in the urease gene complex of only two mutants, 584 and 5B. Probing of these mutants with smaller regions of the urease gene complex revealed that the transposon had inserted into ureA of mutant 5B and into the 5Ј end of ureC of mutant 584 (Fig. 1) . To map the insertion points precisely, PCR was performed with urease-specific primers and a primer directed to the 5Ј end of the transposon. Sequencing of the PCR products showed that the transposon had inserted immediately in front of the ATG start codon of ureA and 30 bp into ureC of mutants 5B and 584, respectively (Fig. 1) . Construction of a urease-negative mutant by site-directed mutagenesis. A defined urease-negative mutant of Y. enterocolitica was constructed by reverse genetics. Briefly, the urease gene complex from Y. enterocolitica A2635, which had been cloned into pRK404, was inactivated by insertion of a kanamycin resistance determinant into the gene encoding UreF. This construct, termed pRKure Ϫ Kn, was conjugated into Y. enterocolitica. Allelic exchange was facilitated by introducing a plasmid, pPH1JI, of the same incompatibility group as pRK404 and selecting for resistance to both gentamicin (encoded by pPH1JI) and kanamycin (encoded by pRKure Ϫ Kn). To confirm that a double-crossover event had taken place, genomic DNA was isolated from the urease-negative mutant, W22u Ϫ , digested with SalI, and analyzed by Southern hybridization with the kanamycin resistance gene and the entire 6.6-kb EcoRI-PvuI urease gene complex as DNA probes. The urease probe hybridized to a single SalI fragment of more than 26 kb in the wild-type strain but to two bands in the recombinant strain because of the presence of a single SalI restriction site in the kanamycin resistance gene (Fig. 2) . The same two SalI fragments in the recombinant strain were also recognized by a probe prepared from the kanamycin resistance cassette (Fig.  2) . Hybridization studies with a probe constructed from pRK404 showed that the vector had not recombined into the chromosome (data not shown).
Growth curves. The urease-negative mutants 584, 5B, and W22u Ϫ were examined for the presence of the virulence plasmid, pYVe227, and for Ca 2ϩ dependence at 37ЊC, since curing of pME305 at 37ЊC may inadvertently have cured pYVe227. The growth of these mutants and the corresponding transcomplemented derivatives in BHI broth at 28 and 37ЊC was also monitored over 33 h to determine if their rates of growth were comparable to that of the wild-type strain. At both 28 and 37ЊC, all urease-negative mutants grew at rates comparable to that of the parent strain (data not shown). The trans-complemented mutants, however, showed slower growth at both temperatures and even after 33 h at 37ЊC did not achieve the same numbers as the parent strain (data not shown).
Susceptibility to acid. Since Y. enterocolitica must be able to survive passage through the stomach at pH Ͻ 3 for up to 2 h before colonizing the intestine, we investigated the ability of Y. enterocolitica to tolerate a range of acidic pH in vitro. The results (Fig. 3A) showed that Y. enterocolitica W22703 survived for 2 h at a pH as low as 2.0 in the presence of urea at concentrations approximating normal levels in serum (3.4 mM), while in the absence of urea, bacteria remained viable only at pH Ն 3.5. There was no change in the pH of the PBS during the 2-h time course of these experiments. To determine the range of urea concentrations which enhanced bacterial (Fig. 3B) . The concentration of urea required for bacterial survival is approximately one-fourth that in the gastric juice of healthy humans (1.4 mM) (23) . Tolerance to low pH also depended on the growth phase of the bacteria, with survival rates increasing during late exponential growth and becoming maximal during stationary phase (Fig. 4) .
Since acid tolerance was evident only in the presence of urea, we investigated whether urease was required by the bacteria to survive under conditions similar to those which they may encounter in the stomach. Hence, the parent strain and three urease-negative mutants derived from it were exposed to acid. The results showed that in contrast to the parent strain, which is acid tolerant, all three urease-negative mutants were sensitive to acid (Table 2 ). When urease activity was restored to the urease-negative mutants by trans-complementation of the urease genes, the ability of the bacteria to tolerate acidic pH increased Ͼ1,000-fold but did not return wild-type levels ( Table 2) , probably because of the reduced amount of urease produced by the trans-complemented mutants compared with the parent strain ( Table 3) .
Effect of urease in vivo. To determine if the ability of Y. enterocolitica to tolerate low pH in vitro was associated with virulence, we compared the abilities of the parent strain, a urease-negative mutant derived from this strain, and a transcomplemented mutant to survive passage through the stomach of mice. The results (Table 4) showed that the numbers of urease-negative mutants recovered from the ileum of mice 90 min after peroral inoculation by ingestion of contaminated water or by gavage were significantly smaller than those of the wild type. After 4 h, however, the numbers of the two strains were similar (data not shown). When urease activity was restored to mutant 584 by complementation in trans, the numbers of viable bacteria recovered from the intestine after 90 min and 4 h were comparable to those of the wild-type strain (Table 4) . Moreover, no significant differences were observed in the viable counts of the wild-type strain and mutant 584 90 min after the bacteria were inoculated directly into the intestine, thus bypassing stomach acid (data not shown).
DISCUSSION
The ability of enteric bacteria to resist killing during transit through the stomach increases the likelihood of intestinal colonization. In this study, we used an in vitro assay to determine if Y. enterocolitica can tolerate the conditions typical of a normal fasting stomach, namely, a pH less than 3.0 and a gastric FIG. 4 . Growth phase induction of acid resistance. Cells from an overnight culture of Y. enterocolitica W22703 were diluted 1:1,000 and grown with shaking at 28ЊC. Aliquots were withdrawn at intervals, and their viable count (F) and ability to survive in PBS (pH 2.5) for 2 h (u) were determined. Percent survival was calculated from comparison of viable counts before and 2 h after exposure to the acidified medium. and their corresponding trans-complemented derivatives were compared for their ability to resist being killed at low pH. The results showed that the wild-type strain and all three transcomplemented urease-negative mutants were acid resistant (defined as an ability to tolerate pH Ͻ 3.0) whereas the ureasenegative mutants were acid sensitive, demonstrating that urease activity is required for survival at pH Ͻ 3.0. Interestingly, no increase in the pH of the reaction mixture was observed during the 2-h time course of these assays. This is probably because Y. enterocolitica exhibits relatively low urease activity (Table 3 ) (2, 29), sufficient to generate only enough ammonia from the hydrolysis of urea to maintain a suitable intracellular or surrounding pH without altering the pH of the macroenvironment. The failure of trans-complementation to restore urease activity to wild-type levels could be due to the absence of hypothetical additional promoters upstream from the cloned urease fragment which may be recognized by alternative sigma factors in wild-type bacteria and which drive expression of the urease operon under altered growth conditions. We are currently investigating the regulation of urease synthesis by Y. enterocolitica in an attempt to isolate these promoters. The ability of urease-producing strains of Y. enterocolitica to tolerate acidic conditions in vitro corresponded to their capacity to survive passage through the stomach of mice. Thus, significantly fewer urease-negative bacteria were recovered from the ileum of mice 90 min after peroral inoculation compared with the wild type or a trans-complemented mutant. At 4 h after inoculation, however, the numbers of urease-negative and wild-type bacteria in the intestine were comparable (data not shown), indicating that the mutants were not defective in terms of their ability to replicate in vivo. This finding agrees with those obtained when the growth rates of urease-negative mutants and wild-type bacteria were compared in vitro. The importance of gastric acid in determining resistance to infection with Y. enterocolitica in humans is reflected in the increased susceptibility of patients with hypoacidity to infection with these bacteria (11) .
A similar correlation between acid resistance and the ability to survive passage through the stomach of mice has been observed with Shigella flexneri (33) . As S. flexneri does not produce urease, expression of acid resistance in this species and in E. coli depends on a functional alternative sigma factor called rpoS. Inactivation of rpoS in these bacteria renders them highly susceptible to acid (33) , reminiscent of urease-negative mutants of Y. enterocolitica. Although Y. enterocolitica also carries an rpoS gene (20) , its role in specifying the ability to tolerate pH Ͻ 3.0 is unknown. The profound acid sensitivity of ureasenegative mutants of Y. enterocolitica, however, suggests that urease is the single most important contributor to acid resistance in this species. Thus, urease appears to act as a virulence factor in Y. enterocolitica by enhancing the survival of bacteria during their passage through the stomach, presumably by neutralizing hydrogen ions which penetrate the bacterial cell wall. Urease may also facilitate the survival of Y. enterocolitica in other low-pH environments, such as the acidic phagosomes of polymorphonuclear leukocytes, which it may encounter during the course of infection. Experiments to determine the contribution of urease to the inherent resistance of Y. enterocolitica to killing by phagocytes (35) are currently in progress.
